GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

8611	Companies
141742	Keywords
77650	Articles
75757	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 06/10/2024 at 23:22, 10 months 2 days ago

GENFIT : Étape historique franchie avec l'approbation accélérée d'Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive par la FDA américaine
GENFIT franchit une étape historique avec l'approbation accélérée d'Iqirvo par la FDA américaine pour la Cholangite Biliaire Primitive en partenariat avec Ipsen

Approbation Accélérée Cholangite Biliaire Primitive GENFIT Iqirvo FDA Américaine
BRIEF

published on 05/29/2024 at 22:15, 10 months 14 days ago

GENFIT présentera ses dernières recherches sur l'ACLF au congrès EASL™ 2024

Collaboration En Recherche GENFIT ACLF Congrès De L'EASL Maladie Du Foie
BRIEF

published on 05/29/2024 at 22:15, 10 months 14 days ago

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024

Research Collaboration GENFIT ACLF EASL Congress Liver Disease
PRESS RELEASE

published on 05/29/2024 at 22:10, 10 months 14 days ago

GENFIT présentera ses dernières avancées dans l'ACLF à l'EASL Congress™ 2024
GENFIT présente ses avancées dans l'ACLF au congrès EASL 2024, détaillant un partenariat de recherche avec l'EF CLIF et des programmes de recherche dans l'ACLF, mettant en avant le potentiel de transformation du traitement

Recherche Traitement GENFIT ACLF EASL
PRESS RELEASE

published on 05/29/2024 at 22:10, 10 months 14 days ago

GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
GENFIT to present latest ACLF research at EASL Congress™ 2024, showcasing collaborative efforts with EF CLIF to advance understanding of ACLF pathophysiology and treatment approaches

Liver Diseases GENFIT ACLF Research EASL Congress 2024 EF CLIF Partnership
BRIEF

published on 05/14/2024 at 22:15, 10 months 29 days ago

GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025

Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF

published on 05/14/2024 at 22:15, 10 months 29 days ago

GENFIT annonce ses résultats financiers du premier trimestre 2024 et dispose d'une trésorerie disponible jusqu'à fin 2025

Industrie Biopharmaceutique Essais Cliniques Baisse Des Revenus Résultats Financiers De GENFIT Situation De Trésorerie
PRESS RELEASE

published on 05/14/2024 at 22:10, 10 months 29 days ago

GENFIT : Information financière du premier trimestre 2024
GENFIT annonce sa situation de trésorerie au 31 mars 2024 et son chiffre d'affaires du premier trimestre 2024, avec des revenus en baisse par rapport à 2023

Chiffre D'affaires Biopharmaceutique Trésorerie Maladies Rares GENFIT
PRESS RELEASE

published on 05/14/2024 at 22:10, 10 months 29 days ago

GENFIT Reports First Quarter 2024 Financial Information
GENFIT reports Q1 2024 financial information showing cash position of €74.0 million and revenues of €1.1 million. Company expects cash to fund operations until Q4 2025

Financial Information Revenues Cash Position Q1 2024 GENFIT

Accesswire

Published on 04/12/2025 at 15:45, 20 hours 42 minutes ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 10 hours ago

Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 12 hours ago

Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/12/2025 at 00:00, 1 day 12 hours ago

Ur-Energy Releases 2024 Year End Results
Published on 04/11/2025 at 23:45, 1 day 12 hours ago

Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 21:45, 1 day 14 hours ago

OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:40, 1 day 17 hours ago

AGM 2025 - Bossard Holding AG Press Release
Published on 04/11/2025 at 18:38, 1 day 17 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 1 day 18 hours ago

EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:10, 1 day 18 hours ago

Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS

Les Echos

Published on 04/11/2025 at 18:30, 1 day 17 hours ago

Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 1 day 17 hours ago

Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 1 day 18 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 1 day 18 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 1 day 18 hours ago

Mise à disposition du Rapport Financier Annuel 2024

View all LES ECHOS COMFI WIRE